Nexalin (NXL) Revenue & Revenue Breakdown
Nexalin Revenue Highlights
Latest Revenue (Y)
$110.75K
Latest Revenue (Q)
$26.84K
Main Segment (Y)
Licensing Fee
Main Geography (Y)
UNITED STATES
Nexalin Revenue by Period
Nexalin Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $110.75K | -91.62% |
2022-12-31 | $1.32M | 817.20% |
2021-12-31 | $144.06K | -40.69% |
2020-12-31 | $242.91K | 17.13% |
2019-12-31 | $207.38K | - |
Nexalin Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $26.84K | -65.88% |
2024-03-31 | $78.67K | 283.09% |
2023-12-31 | $20.54K | -14.83% |
2023-09-30 | $24.11K | -32.15% |
2023-06-30 | $35.54K | 16.30% |
2023-03-31 | $30.56K | -20.47% |
2022-12-31 | $38.42K | -92.95% |
2022-09-30 | $545.32K | 31.63% |
2022-06-30 | $414.29K | 28.13% |
2022-03-31 | $323.32K | 1247.23% |
2021-12-31 | $24.00K | -57.12% |
2021-09-30 | $55.97K | 91.99% |
2021-06-30 | $29.15K | -16.57% |
2021-03-31 | $34.94K | 7.51% |
2020-12-31 | $32.50K | -11.93% |
2020-09-30 | $36.91K | -57.46% |
2020-06-30 | $86.75K | -0.00% |
2020-03-31 | $86.75K | - |
Nexalin Revenue Breakdown
Nexalin Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 |
---|---|---|
Other | $1.37K | $26.41K |
Equipment | $27.30K | $26.78K |
Licensing Fee | $82.08K | $79.19K |
Device Sales | - | $1.16M |
Quarterly Revenue by Product
Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 |
---|---|---|---|---|---|---|---|
Licensing Fee | $21.56K | $19.51K | $18.66K | $20.03K | $23.87K | $18.63K | $21.11K |
Equipment | $1.51K | $10.62K | $5.18K | $5.10K | $6.40K | $4.75K | $4.10K |
Other | $100.00 | $2.00 | $270.00 | $807.00 | $290.00 | $275.00 | $110.00 |
Device Sales | $55.50K | $9.60K | - | $520.00K | - | - | - |
Nexalin Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 |
---|---|---|
UNITED STATES | $107.13K | $113.54K |
CHINA | $3.61K | $1.21M |
Quarterly Revenue by Country
Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 |
---|---|---|---|---|---|---|---|
UNITED STATES | $23.17K | $27.13K | $24.11K | $25.33K | $30.56K | $23.68K | $25.32K |
CHINA | - | - | $10.21K | $14.75K | $520.00K | - | - |
Nexalin Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
LIVN | LivaNova | $1.15B | $318.11M |
KIDS | OrthoPediatrics | $148.73M | $52.80M |
SRDX | Surmodics | $132.58M | $30.34M |
NPCE | NeuroPace | $65.42M | $18.12M |
IRIX | IRIDEX | $51.87M | $12.63M |
AZYO | Elutia | $49.19M | $6.13M |
LNSR | LENSAR | $42.16M | $10.59M |
SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
OSA | ProSomnus | $27.65M | $7.46M |
INVO | INVO Bioscience | $3.02M | $1.58M |
MOTS | Motus GI | $319.00K | $64.00K |
AIMD | Ainos | $122.11K | - |
NXL | Nexalin | $110.75K | $26.84K |
BJDX | Bluejay Diagnostics | - | - |
MODD | Modular Medical | - | - |
NXL Revenue FAQ
What is Nexalin’s yearly revenue?
Nexalin's yearly revenue for 2023 was $110.75K, representing a decrease of -91.62% compared to 2022. The company's yearly revenue for 2022 was $1.32M, representing an increase of 817.20% compared to 2021. NXL's yearly revenue for 2021 was $144.06K, representing a decrease of -40.69% compared to 2020.
What is Nexalin’s quarterly revenue?
Nexalin's quarterly revenue for Q2 2024 was $26.84K, a -65.88% decrease from the previous quarter (Q1 2024), and a -24.48% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $78.67K, a 283.09% increase from the previous quarter (Q4 2023), and a 157.43% increase year-over-year (Q1 2023). NXL's quarterly revenue for Q4 2023 was $20.54K, a -14.83% decrease from the previous quarter (Q3 2023), and a -46.55% decrease year-over-year (Q4 2022).
What is Nexalin’s revenue growth rate?
Nexalin's revenue growth rate for the last 3 years (2021-2023) was -23.13%, and for the last 5 years (2019-2023) was -46.60%.
What are Nexalin’s revenue streams?
Nexalin's revenue streams in c 23 are Other, Equipment, and Licensing Fee. Other generated $1.37K in revenue, accounting 1.24% of the company's total revenue, down -94.82% year-over-year. Equipment generated $27.3K in revenue, accounting 24.65% of the company's total revenue, up 1.95% year-over-year. Licensing Fee generated $82.08K in revenue, accounting 74.11% of the company's total revenue, up 3.65% year-over-year.
What is Nexalin’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Nexalin was Licensing Fee. This segment made a revenue of $82.08K, representing 74.11% of the company's total revenue.